Vice President, Regulatory Affairs (Advertising, Promotion, and Labeling)
Who We Are:
Xenon Pharmaceuticals (NASDAQ:XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team.
What We Do:
We are advancing an exciting product pipeline to address indications with high unmet medical need, including epilepsy, depression and pain. Our Phase 3 azetukalner program represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. In March 2026, we announced positive topline data from our Phase 3 X-TOLE2 study of azetukalner in focal onset seizures (FOS), and we anticipate submitting a New Drug Application to the Food and Drug Administration in the third quarter of 2026. Our Phase 3 epilepsy program also includes a second FOS study, X-TOLE3, which would support regulatory submissions outside the U.S., and the X-ACKT study in primary generalized tonic-clonic seizures, which would support regulatory submissions for an additional epilepsy indication. We also have multiple Phase 3 azetukalner clinical trials underway in major depressive disorder (MDD) and bipolar depression (BPD), based on topline data from our Phase 2 X-NOVA clinical trial. In addition, we are proud of our strong heritage in human genetics, deep understanding of ion channel biology, and expertise in novel chemistries to enable potent, selective ion channel targeting, and continue to advance an early-stage pipeline of novel therapeutic candidates. In 2025, we initiated Phase 1 trials for XEN1701 (targeting Nav1.7) and XEN1120 (targeting Kv7). Nav1.7 and Kv7 are important pain targets, and data from these Phase 1 studies are expected in 2026 to support Phase 2 proof-of-concept studies in acute pain. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.
About the Role:We are seeking a Vice President, Regulatory Affairs (Advertising, Promotion, and Labeling) to join our team. The Vice President, Regulatory Affairs will establish and lead two critical functions—Commercial Regulatory Affairs and Regulatory Labeling—for a growing biotech organization. This executive will develop strategy, build teams, and implement systems to ensure compliance with FDA and global health authority requirements for promotional materials and product labeling. The role provides strategic leadership across Marketing, Medical Affairs, Legal, Clinical, and Commercial teams, guiding risk-based decisions and enabling compliant business growth. Responsibilities include regulatory intelligence, digital and global promotional oversight, labeling governance, and direct engagement with regulatory agencies.
This position reports to the Senior Vice President, Regulatory Affairs and Medical Writing, and will be based out of Boston, MA, USA in our Needham office. We will consider remote locations for exceptional candidates. Hybrid positions require a minimum of two onsite days per week. On-site positions require up to five on-site days per week.
RESPONSIBILITIES:Advertising & PromotionBuild and lead the Commercial Regulatory Affairs function, including policies, processes, and governance for promotional review.
Serve as internal expert on FDA regulations, guidance, and enforcement trends governing advertising and promotion of prescription drugs.
Provide strategic and operational leadership to Marketing, Medical Affairs, Legal, and Clinical teams in developing compliant promotional materials aligned with business objectives.
Conduct detailed review of clinical evidence supporting proposed claims; ensure consistency with FDA-approved labeling.
Oversee review and approval of promotional materials across all channels (digital, print, social media, training, press releases).
Serve as primary contact for FDA’s OPDP, managing advisory comment requests, negotiations, and pre-clearance of launch materials.
Direct timely submission of all approved promotional materials to FDA on Form 2253.
Monitor regulatory developments and enforcement actions; proactively update stakeholders and guide risk mitigation strategies.
Establish and lead the Regulatory Labeling function, including governance, processes, and systems for labeling development and maintenance.
Oversee creation and lifecycle management of prescribing information, patient labeling, and packaging components for all products.
Ensure labeling compliance with FDA and global health authority requirements; manage updates driven by regulatory changes, safety signals, or new data.
Partner with Clinical, Medical, and Commercial teams to align labeling strategy with product development and commercialization plans.
Implement labeling change control processes and ensure timely submission of updated labeling to regulatory authorities.
Develop labeling standards and templates; ensure consistency across global markets.
Represent labeling function in cross-functional teams and regulatory interactions.
Recruit, develop, and mentor regulatory professionals; build high-performing teams for both functions.
Drive a culture of excellence, innovation, and accountability; reward initiative and performance.
Establish KPIs for regulatory review and labeling processes; lead continuous improvement initiatives.
Develop and propose short- and long-term objectives for the function in accordance with overall Company strategies and plans
Plan and manage budget proposals and approved budgets in accordance with the Company’s strategic and operating plans and Finance policies
Recruit, lead, direct, develop, coach and evaluate direct reports, if any, in accordance with the Company’s Human Resource policies and practices
Act in accordance with Company policies, including, for example, the Code of Business Conduct and Ethics and ensure policies are understood and followed by direct reports, if any
Some international travel may be required
Other duties as assigned
Bachelor’s degree in a scientific discipline; advanced degree (MD, PharmD, PhD) strongly preferred.
Minimum of 15 years of Regulatory leadership roles of increasing responsibility with small and large multi-national biopharma companies. Significant direct experience in advertising, promotion, and labeling required.
Comprehensive knowledge of FDA and global regulations for labeling and promotional compliance.
Experience with global product launches and lifecycle management.
Strong strategic and operational skills; ability to balance short-term needs with long-term vision.
Strong interpersonal and leadership skills to work both independently and collaboratively as part of multidisciplinary teams in a fast-paced, distributed and highly matrixed environment.
Demonstrated experience in building regulatory teams, systems and processes appropriate to scale.
High organizational awareness and ability to connect cross-functional priorities.
Our Total Rewards program includes base salary, target bonus, and stock options, as well as a full range of benefits including medical, dental, vision, short-& long-term disability, accidental death & dismemberment, and life insurance programs, Employee Assistance Program, travel insurance, and retirement savings programs with company matching contributions.
Xenon encourages time to rest and re-charge through vacation, personal days, sick days, and an end-of-year company shutdown. Xenon highly values employee development and has an expanding Training, Learning & Development program, including a Tuition Assistance program for advanced degrees.
Similar Jobs
What We Do
Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. Our lead molecule, azetukalner, is a novel, potent, selective Kv7 potassium channel opener in Phase 3 clinical trials for the treatment of epilepsy, major depressive disorder (MDD) and bipolar depression (BPD). We are also advancing an early-stage portfolio of multiple promising potassium and sodium channel modulators, including Kv7 and Nav1.7 programs in Phase 1 development for the potential treatment of pain. We have offices in Vancouver, British Columbia, and Boston, Massachusetts.








